Recent Publications


  • HOME
  • Recent Publications

Recent Publications

2017 | 2016 | 2015 | 2014 | 2013

Ito, M., Hayashi, K., Minamisawa, T., Homma, S., Koido, S. and Shiba, K.
Encryption of agonistic motifs for TLR4 into artificial antigens augmented the maturation of antigen-presenting cells.
PLoS One, 12, e0188934 (2017)
Yoshida, M., Hibino, K., Yamamoto, S., Matsumura, S., Yajima, Y. and Shiba, K.
Preferential capture of EpCAM-expressing extracellular vesicles on solid surfaces coated with an aptamer-conjugated zwitterionic polymer.
Biotechnol Bioeng, in press (2017)
Tanaka, M., Yoshimoto, T. and Nakamura, T.
A double-edged sword: the world according to Capicua in cancer.
Cancer Sci., in press (2017)
Osako, T., Iwase, T., Ushijima, M., Yonekura, R., Ohno, S. and Akiyama, F.
A new molecular-based lymph node staging classification determines the prognosis of breast cancer patients.
Br. J. Cancer., in press (2017)
Takemoto, A., Miyata, K. and Fujita, N.
Platelet-activating factor podoplanin: from discovery to drug development.
Cancer and metastasis reviews, 36, 225-234 (2017)
Katayama, R.
Therapeutic strategies and mechanisms of drug resistance in Anaplastic Lymphoma Kinase (ALK)-rearranged lung cancer.
Pharmacol. Ther., 117, 1-8 (2017)
Fuse, J. M., Okada, K., Oh-hara, T., Ogura, H., Fujita, N. and Katayama, R.
Mechanisms of resistance to NTRK inhibitors and therapeutic strategies in NTRK1-rearranged cancers.
Mol. Cancer Ther., 16, 2130-2143 (2017)
Ogura, H., Nagatake-Kobayashi, Y., Adachi, J., Tomonaga, T., Fujita, N. and Katayama, R.
TKI-addicted ROS1-rearranged cells are destined to survival or death by the intensity of ROS1 kinase activity.
Sci. Rep., 7, 5519 (2017)
N. Tsuyama, R. Asaka, A. Dobashi, S. Baba, Y. Mishima, K. Ueda, M. Oguchi, H. Tsuji, K. hatake and K. Takeuchi.
Epstein-Barr virus-negative extranodal “true” natural killer-cell lymphoma harbouring a KDM6A mutation.
Hematol. Oncol., in press (2017)
Miyata, K., Takemoto, A., Okumura, S., Nishio, M. and Fujita, N.
Podoplanin enhances lung cancer cell growth in vivo by inducing platelet aggregation.
Sci. Rep., 7, 4059 (2017)

Return to Top of Page